METHODS	Sixty-nine outpatients scheduled for carpal tunnel syndrome repair with axillary plexus block were randomly assigned to one of three groups that received saline solution in the axillary plexus and subcutaneously ( group 1 ) , 500 microg neostigmine in the axillary plexus and saline solution subcutaneously ( group 2 ) , or saline solution in the axillary plexus and 500 microg neostigmine subcutaneously ( group 3 ) .\